BioLASCO Taiwan Co., Ltd. (6662.TWO)
TWD 32.5
(1.56%)
TWD 32.5
(1.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -84.76 Million TWD | 17.35% |
| 2022 | -102.55 Million TWD | 22.3% |
| 2021 | -131.99 Million TWD | -3.65% |
| 2020 | -127.33 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -47.85 Million TWD | 43.55% |
| 2024 Q2 | 19.28 Million TWD | 140.31% |
| 2023 Q4 | -84.76 Million TWD | -34.7% |
| 2023 FY | -84.76 Million TWD | 17.35% |
| 2023 Q2 | -78.61 Million TWD | -5.07% |
| 2023 Q3 | -62.92 Million TWD | 19.95% |
| 2023 Q1 | -74.81 Million TWD | 0.0% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 67.913% |
| Level Biotechnology Inc. | -453.9 Million TWD | 81.326% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 29.698% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 56.841% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 310.508% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 377.203% |
| Visgeneer Inc. | 31.28 Million TWD | 370.947% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 87.546% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 36.863% |
| Neith Corporation | -150.31 Million TWD | 43.608% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -47.01% |
| Enimmune corporation | -314.15 Million TWD | 73.019% |
| TaiRx, Inc. | -147.86 Million TWD | 42.677% |
| EirGenix Inc. | -4.58 Billion TWD | 98.153% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 170.127% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -31.781% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 73.296% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -327.815% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 267.004% |
| RBC Bioscience Corporation | 422.18 Million TWD | 120.077% |
| BiOptic Inc. | 12.59 Million TWD | 773.15% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -10.019% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 16.478% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 48.683% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 126.92% |
| Mycenax Biotech Inc. | 207 Million TWD | 140.947% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 113.638% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 366.475% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 116.958% |
| GlycoNex Incorporation | -148.56 Million TWD | 42.946% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 161.425% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 67.719% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 97.366% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 91.025% |
| VBI | -25.31 Million TWD | -234.82% |
| CHO Pharma, Inc. | -203.79 Million TWD | 58.407% |
| NaviFUS Corp. | -123.12 Million TWD | 31.159% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 214.466% |
| Sinew Pharma Inc. | -160.34 Million TWD | 47.137% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 64.958% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 74.876% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 79.458% |
| AP Biosciences Inc | -196.52 Million TWD | 56.87% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 112.307% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -641.13% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 89.784% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 106.245% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 79.569% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 59.509% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 41.081% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 74.356% |
| TCI GENE Inc. | -689.25 Million TWD | 87.702% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 28.733% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 93.526% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 513.821% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 16.793% |
| PharmaEngine, Inc. | -860.8 Million TWD | 90.153% |
| Savior Lifetec Corporation | -812.54 Million TWD | 89.568% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 71.743% |
| OBI Pharma, Inc. | -398.22 Million TWD | 78.715% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 76.804% |
| Acepodia, Inc. | -6.02 Billion TWD | 98.592% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 97.508% |